Waters (NYSE:WAT) Stock Sold Off Rep. Kevin Hern

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Waters Corporation (NYSE:WAT). In a filing disclosed on September 01st, the Representative disclosed that they had sold between $1,001 and $15,000 in Waters stock on August 13th. The trade occurred in the Representative’s “HERN FAMILY REVOCABLE TRUST” account.

Representative Kevin Hern also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Marsh & McLennan Companies (NYSE:MRSH) on 8/24/2026.
• Sold $15,001 – $50,000 in shares of Medtronic (NYSE:MDT) on 8/24/2026.
• Sold $50,001 – $100,000 in shares of Home Depot (NYSE:HD) on 8/24/2026.
• Sold $50,001 – $100,000 in shares of Procter & Gamble (NYSE:PG) on 8/24/2026.
• Sold $1,001 – $15,000 in shares of Lowe’s Companies (NYSE:LOW) on 8/24/2026.
• Sold $15,001 – $50,000 in shares of Microsoft (NASDAQ:MSFT) on 8/21/2026.
• Sold $1,001 – $15,000 in shares of Veralto (NYSE:VLTO) on 8/21/2026.
• Sold $15,001 – $50,000 in shares of Honeywell Aerospace (NASDAQ:HONA) on 8/19/2026.
• Sold $1,001 – $15,000 in shares of Colgate-Palmolive (NYSE:CL) on 8/19/2026.
• Sold $1,001 – $15,000 in shares of Biogen (NASDAQ:BIIB) on 8/18/2026.

Waters Stock Up 0.3%

Shares of NYSE WAT opened at $413.61 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.86 and a debt-to-equity ratio of 0.32. The company has a market cap of $40.64 billion, a P/E ratio of 103.14, a P/E/G ratio of 2.40 and a beta of 1.19. Waters Corporation has a 52 week low of $282.77 and a 52 week high of $426.22. The business has a 50-day simple moving average of $391.24 and a two-hundred day simple moving average of $351.04.

Waters (NYSE:WAT) last announced its quarterly earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share for the quarter, beating the consensus estimate of $3.01 by $0.04. Waters had a return on equity of 11.27% and a net margin of 3.58%.The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.62 billion. During the same period in the prior year, the business posted $2.95 earnings per share. The company’s revenue was up 113.3% on a year-over-year basis. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Research analysts anticipate that Waters Corporation will post 14.56 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have commented on WAT. The Goldman Sachs Group raised their price target on shares of Waters from $380.00 to $425.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Stifel Nicolaus set a $420.00 price objective on Waters in a research note on Wednesday, August 5th. Citigroup boosted their target price on Waters from $425.00 to $470.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Royal Bank Of Canada upped their target price on Waters from $435.00 to $475.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Finally, Guggenheim reaffirmed a “buy” rating and issued a $440.00 price target on shares of Waters in a report on Wednesday, July 8th. Three research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $424.35.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Anchor Investment Management LLC bought a new position in shares of Waters during the 1st quarter valued at about $27,000. Resources Management Corp CT ADV bought a new stake in Waters in the 1st quarter worth approximately $27,000. PenderFund Capital Management Ltd. purchased a new stake in Waters in the second quarter worth approximately $28,000. Zions Bancorporation National Association UT grew its position in Waters by 121.2% during the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 40 shares during the last quarter. Finally, Vision Retirement LLC bought a new position in Waters during the first quarter valued at approximately $29,000. Institutional investors own 94.01% of the company’s stock.

Insiders Place Their Bets

In other Waters news, Director Christopher Kuebler sold 3,626 shares of the company’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the sale, the director directly owned 17,808 shares in the company, valued at $7,086,515.52. This represents a 16.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.31% of the stock is owned by corporate insiders.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.

Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.

Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.